Colesevelam Hcl
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Nonalcoholic Steatohepatitis
Conditions
Nonalcoholic Steatohepatitis
Trial Timeline
Feb 1, 2010 → Feb 1, 2012
NCT ID
NCT01066364About Colesevelam Hcl
Colesevelam Hcl is a phase 2 stage product being developed by Daiichi Sankyo for Nonalcoholic Steatohepatitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01066364. Target conditions include Nonalcoholic Steatohepatitis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01066364 | Phase 2 | Completed |
| NCT00476710 | Pre-clinical | Completed |
Competing Products
20 competing products in Nonalcoholic Steatohepatitis